Intratumor heterogeneity: the rosetta stone of therapy resistance

A Marusyk, M Janiszewska, K Polyak - Cancer cell, 2020 - cell.com
Advances in our understanding of molecular mechanisms of tumorigenesis have translated
into knowledge-based therapies directed against specific oncogenic signaling targets …

Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next‐Generation Therapeutics

N Singh, GR Sherin, G Mugesh - Angewandte Chemie, 2023 - Wiley Online Library
Nanozymes, nanomaterials with enzyme‐mimicking activity, have attracted tremendous
interest in recent years owing to their ability to replace natural enzymes in various …

Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations

JJ Salk, MW Schmitt, LA Loeb - Nature Reviews Genetics, 2018 - nature.com
Mutations, the fuel of evolution, are first manifested as rare DNA changes within a population
of cells. Although next-generation sequencing (NGS) technologies have revolutionized the …

Promises and challenges of adoptive T-cell therapies for solid tumours

M Morotti, A Albukhari, A Alsaadi, M Artibani… - British journal of …, 2021 - nature.com
Cancer is a leading cause of death worldwide and, despite new targeted therapies and
immunotherapies, many patients with advanced-stage-or high-risk cancers still die, owing to …